Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.680
+0.310 (9.20%)
At close: May 12, 2025, 4:00 PM
3.500
-0.180 (-4.89%)
After-hours: May 12, 2025, 5:15 PM EDT
Pulmonx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Pulmonx stock have an average target of 12.07, with a low estimate of 7.50 and a high estimate of 17. The average target predicts an increase of 227.99% from the current stock price of 3.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pulmonx stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +307.61% | May 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +144.57% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +361.96% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +361.96% | Mar 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +361.96% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
98.85M
from 83.79M
Increased by 17.97%
Revenue Next Year
117.51M
from 98.85M
Increased by 18.88%
EPS This Year
-1.58
from -1.44
EPS Next Year
-1.44
from -1.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.4M | 124.2M | 186.6M | ||
| Avg | 98.9M | 117.5M | 146.6M | ||
| Low | 93.6M | 108.2M | 126.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2% | 25.6% | 58.8% | ||
| Avg | 18.0% | 18.9% | 24.8% | ||
| Low | 11.7% | 9.4% | 8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.58 | -1.28 | -0.23 | ||
| Avg | -1.58 | -1.44 | -1.07 | ||
| Low | -1.58 | -1.55 | -1.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.